Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Colonic Neoplasms

• Neoadjuvant Tislelizumab With Chemotherapy for the Treatment of MSS Colon Cancer
• Neoadjuvant Chemotherapy for Obstructive Colon cancER First Treated by cOlostomy
• A Study to Investigate Ompenaclid Combined With FOLFIRI Plus Bevacizumab in Advanced/Metastatic Colorectal Cancer
• A Clinical Trial Evaluating the Efficacy and Safety of IBI310 in Combination With Sintilimab, for Neoadjuvant Treatment of MSI-H/dMMR Resectable Colon Cancer
• XKDCT080 in GCC-positive Recurrent or Refractory Solid Tumors With Single Center, Single Arm, and Dose Escalation
• Neoadjuvant Chemoimmunotherapy for Resectable Non-Metastatic Proficient Mismatch Repair (PMMR) Colon Cancer
• Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
• A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid Tumors
• Neoadjuvant Immunotherapy in Locally Advanced Colon Cancers
• Serplulimab Combined With FOLFIRI and Bevacizumab in the Treatment of Colon Cancer Peritoneal Metastases
• Short-course Radiotherapy Combined With Chemotherapy and Pd-1 Inhibitor for Locally Advanced Colon Cancer(TORCH-C)
• Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon Cancer
• Xian-Lian-Jie-Du Optimization Decoction as an Adjuvant Treatment for Prevention of Recurrence of Colon Cancer
• Response to Immunotherapy in MMR-deficient Localized Colon Cancer
• Comparison of Oral Lactulose Versus Polyethylene Glycol for Bowel Preparation in Low-risk Patients
• Propofol With Clonidine and Ketamine Throughout Colon Cancer Surgery
• Platform Study of Circulating Tumor DNA Directed Adjuvant Chemotherapy in Colon Cancer
• Study of an Individualized Vaccine Targeting Neoantigens in Combination With Immune Checkpoint Blockade for Patients With Colon Cancer
• Repurposing the Antipsychotic Drug Chlorpromazine as Adjuvant Therapeutic Agent for Resected Stage III Colon Cancer
• Tranexamic Acid During Colonic Endoscopic Resection Procedures
• To Determine the Efficacy and Safety of Envafolimab Combined With XELOX for Locally Advanced Colon Cancer
• Testing the Addition of Nivolumab to Standard Treatment for Patients With Metastatic or Unresectable Colorectal Cancer That Have a BRAF Mutation
• Chemoprophylaxis With Rivaroxaban for Lower Limb Deep Vein Thrombosis in Colorectal Cancer
• Intravenous Iron Infusion on Chemotherapy-induced Anemia
• Microbiotic Product (NBT-NM108) to Reduce Chemotherapy-Induced Diarrhea
• Argipressin's Influence on Blood Loss and Inflammatory Response During Hepatic Resection
• Clinical Trial on HIPEC With Mitomycin C in Colon Cancer Peritoneal Metastases (GECOP-MMC)
• Single Arm Study of Neoadjuvant Dostarlimab in Stage II and III Deficient Mismatch Repair Colon Cancers
• A Phase II Study of Tislelizumab as Adjuvant Therapy for Patients With Stage Ⅱ and Stage Ⅲ Colon Cancer and dMMR/MSI.
• Camrelizumab Combined With Neoadjuvant Chemotherapy After Stent Placement for Left-Sided Obstructive Colonic Cancer
• Neoadjuvant FOLFOXIRI Versus Immediate Surgery for Stage II and III Colon Cancers
• Adjuvant FOLFOXIRI for High-risk Stage III Colon Cancer
• A Single Arm Phase II Study to Evaluate Treatment With Gevokizumab in Patients With Stage II/III Colon Cancer Who Are ctDNA-positive After Curative Surgery and Adjuvant Chemotherapy
• Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
• Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors
• A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations
• Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients
• Exploiting Circulating Tumour DNA to Intensify the Postoperative Treatment Resected Colon Cancer Patients
• A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)
• Abdominal Drainage vs Postoperative Antibiotico-prophylaxis vs Control in Laparoscopic Right Hemicolectomy With Intracorporeal Anastomosis for Right Colon Cancer
• Adagrasib in Combination With BI 1701963 in Patients With Cancer (KRYSTAL 14)
• Immunotherapy Versus Chemotherapy as Adjuvant Therapy for Colon Cancer With MSI-H or POLE/ POLD1 Mutations
• Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome
• Outcome of Neoadjuvant Chemotherapy for Obstructive Colon Cancer
• FOLFOXIRI Plus Cetuximab Versus FOLFOXIRI Plus Bevacizumab in Conversion Therapy of Right-sided Colon Cancer Liver Metastases
• Effect of Low-dose Interferon-alfa2a on Peri-operative Immune Suppression
• A Prospective Study Utilizing Circulating Cell Free DNA (cfDNA) Use in the Detection of RAS Mutations in Patients With Advanced Colorectal Cancer.
• 18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases
• Phase I/II Trial of the Combination of Bintrafusp Alfa (M7824), Entinostat and NHS-IL12 (M9241) in Patients With Advanced Cancer
• Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Patients With Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
• Preoperative i.v. Iron Substitution in Patients With Colon Cancer
• Neoadjuvant Therapy for Locally Advanced Right-sided Colon Cancer
• LY3214996 and Cetuximab Alone or in Combination With Abemaciclib for the Treatment of Unresectable or Metastatic Colorectal Cancer
• SX-682 and Nivolumab for the Treatment of RAS-Mutated, MSS Unresectable or Metastatic Colorectal Cancer, the STOPTRAFFIC-1 Trial
• Immunoscore as Decision Guidance for Adjuvant Chemotherapy in Colon Cancer
• The Value of Palliative Primary Tumor Resection in Metastatic Colon Cancer
• Study of ASN004 in Patients With Advanced Solid Tumors
• Triplezumab Combined With CAPEOX Regimen in Neoadjuvant Therapy for Locally Advanced Colon Cancer
• Regorafenib, Ipilimumab and Nivolumab for the Treatment of Chemotherapy Resistant Microsatellite Stable Metastatic Colorectal Cancer
• Lymph Node Ratio and Kras Mutation in R Colon Cancer
• A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Patients With Metastatic Colorectal Cancer
• Volatile Anaesthesia and Perioperative Outcomes Related to Cancer: The VAPOR-C Trial
• Preoperative Endoscopic Treatment With Fosfomycin and Metronidazole in Patients With Right-sided Colon Cancer and Colon Adenoma (MEFO-trial)
• Adjuvant Chemotherapy in High Risk Stage II Colon Cancer
• TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon Cancer
• Post-surgical Liquid Biopsy-guided Treatment of Stage III and High-risk Stage II Colon Cancer Patients: the PEGASUS Trial
• Anesthesia and Cancer Study: Colon Cancer
• Pembrolizumab in Early Stage Colon Cancer
• Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for the Treatment of Resectable, Refractory, or Recurrent Rhabdomyosarcoma in Pediatric Patients, T.O.A.S.T. I.T. Study
• The Clinical Study of Adjuvant Chemotherapy on Intestinal and Urethral Flora in Patients With Gastric and Colon Cancer
• Dasatinib in Preventing Oxaliplatin-Induced Peripheral Neuropathy in Patients With Colorectal Cancer Receiving FOLFOX and Bevacizumab
• Preoperative Nivolumab in Patients With Locally Advanced Colon Cancer (T3 or T4): a Window-of-opportunity Study
• CIRCULATING TUMOR DNA BASED DECISION FOR ADJUVANT TREATMENT IN COLON CANCER STAGE II
• TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO Study
• Immunotherapy With Y90-RadioEmbolization for Metastatic Colorectal Cancer
• Circulating Tumour DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II Evaluation
• Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery
• Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer
• Encorafenib, Binimetinib, and Nivolumab in Treating Patients With Microsatellite Stable BRAF V600E Metastatic Colorectal Cancer
• The Effectiveness of High-dose Intravenous Vitamin c With Very Low Carbohydrate Diet for Terminal Colon Cancer Patients
• Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer
• A Trial of CXD101 in Combination With Nivolumab in Patients With Metastatic Microsatellite-Stable Colorectal Cancer
• Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer
• The Efficacy of JS001 Combined With Chemotherapy in Patients With Locally Advanced Colon Cancer
• Niraparib and Panitumumab in Patients With Advanced or Metastatic Colorectal Cancer
• Binimetinib and Palbociclib or TAS-102 in Treating Patients With KRAS and NRAS Mutant Metastatic or Unresectable Colorectal Cancer
• Preoperative High Protein vs Immunodiet in Surgical Cancer Patients
• Neoadjuvant Chemoradiotherapy Versus Neoadjuvant Chemotherapy For Unresectable Locally Advanced Colon Cancer
• Toripalimab With or Without Celecoxib as Neoadjuvant Therapy in Resectable dMMR/MSI-H Colorectal Cancer
• Foxy-5 as Neo-Adjuvant Therapy in Subjects With Wnt-5a Low Colon Cancer
• Pembrolizumab After Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver and Who Are Undergoing Liver Surgery
• Circulating Cell-Free Tumor DNA Testing in Guiding Treatment for Patients With Advanced or Metastatic Colorectal Cancer
• Avelumab Plus 5-FU Based Chemotherapy as Adjuvant Treatment for Stage 3 MSI-High or POLE Mutant Colon Cancer
• Effect of Adding Simethicone to Split-dose Polyethylene Glycol for Bowel Preparation in a Screening Colonoscopy Setting
• Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer
• Nivolumab and Metformin in Patients With Treatment Refractory MSS Colorectal Cancer
• Targeted Polymeric Nanoparticles Loaded With Cetuximab and Decorated With Somatostatin Analogue to Colon Cancer
• Sym004 Versus TAS-102 in Patients With mCRC
• Herbal Treatment to Improve Chemotherapy Delivery
• Regorafenib and Nivolumab in Mismatch Repair (MMR) Refractory Colorectal Cancer
• Study of PI3Kinase Inhibition (Copanlisib) and Anti-PD-1 Antibody Nivolumab in Relapsed/Refractory Solid Tumors With Expansions in Mismatch-repair Proficient (MSS) Colorectal Cancer
• Treatment of Colorectal Liver Metastases With Immunotherapy and Bevacizumab
• OMega-3 Fatty Acid for the Immune Modulation of Colorectal Cancer
• Regorafenib and Pembrolizumab in Treating Participants With Advanced or Metastatic Colorectal Cancer
• A Study of Bevacizumab, Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (A-FOLFOXIRI) Compared With Bevacizumab, Infusional Fluorouracil, Leucovorin, and Irinotecan/Oxaliplatin (A-FOLFIRI/FOLFOX) as First-line Treatment for Metastat
• Interest of the Nefopam and PCA Morphine Combination for Postoperative Analgesia in Patients Undergoing Colon Surgery
• A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies
• Peripheral Parenteral Nutrition vs Conventional Fluid in Colorectal Resection in ERAS
• Chemotherapy and/or Metastasectomy in Treating Patients With Metastatic Colorectal Adenocarcinoma With Lung Metastases
• Savolitinib in Treating Patients With MET Amplified Metastatic or Unresectable Colorectal Cancer
• Guadecitabine and Nivolumab in Treating Refractory Metastatic Colorectal Cancer
• Sym004 Versus Futuximab or Modotuximab in Patients With mCRC
• The Effects of Mechnikov Probiotics on Symptom and Surgical Outcome
• Cetuximab Therapy for Third Line Rechallenge in Metastatic Colorectal Cancer
• Combined Immunotherapy and Radiosurgery for Metastatic Colorectal Cancer
• Mechanical Bowel Preparation and Oral Antibiotics Before Colon Cancer Surgery
• ASPIRIN Trial Belgium
• A Study of TAK-164 in Participants With Advanced Gastrointestinal (GI) Cancer Expressing Guanylyl Cyclase C (GCC)
• Palbociclib and Cetuximab in Metastatic Colorectal Cancer
• PhII Trial Panitumumab, Nivolumab, Ipilimumab in Kras/Nras/BRAF Wild-type MSS Refractory mCRC
• EPA for Metastasis Trial 2
• Study of Durvalumab (MEDI4736) (Anti-PD-L1) and Trametinib (MEKi) in MSS Metastatic Colon Cancer
• Neoadjuvant FOLFOX Chemotherapy for Patients With Locally Advanced Colon Cancer
• A Study of ASN007 in Patients With Advanced Solid Tumors
• Ginseng in Decreasing Cancer-Related Fatigue After Treatment in Cancer Survivors
• Celecoxib, Recombinant Interferon Alfa-2b, and Rintatolimod in Treating Patients With Colorectal Cancer Metastatic to the Liver
• Pembrolizumab, Capecitabine, and Bevacizumab in Treating Patients With Microsatellite Stable Colorectal Cancer That Is Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
• METIMMOX: Colorectal Cancer METastasis - Shaping Anti-tumor IMMunity by OXaliplatin
• S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
• EMI-137 in Laparoscopic Colonic Resections
• Metformin Treatment for Colon Cancer
• Trametinib and Trifluridine and Tipiracil Hydrochloride in Treating Patients With Colon or Rectal Cancer That is Advanced, Metastatic, or Cannot Be Removed by Surgery
• Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in Resected High Risk Colon Cancer Patients
• LEAn Body Mass Normalization of OXaliplatin Based Chemotherapy
• Impact of Adjuvant Chemotherapy in Patients With Colon Cancer
• Efficacy of Postoperative Adjuvant Chemotherapy for Stage II Colon Cancer With High Risk Factors(EPAC1)
• Ultrasound Guided Transversus Abdominis Plane(TAP) Block in Intensive Care Unit
• Reduced Dose of Prophylactic Dexamethasone for Elderly Patients Receiving Moderate Emetogenic Chemotherapy
• A Study of LOXO-292 in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer
• A "Window Trial" on Boswellia for Breast Cancer Primary Tumors
• Study of QRH-882260 Heptapeptide Application in the Colon
• Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Patients With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors
• Nivolumab, Ipilimumab and COX2-inhibition in Early Stage Colon Cancer: an Unbiased Approach for Signals of Sensitivity
• TVB 2640 for Resectable Colon Cancer Other Resectable Cancers; a Window Trial.
• Adjuvant Chemotherapy In Elderly With Colon Cancer Stage III
• Proactive Management of Endoperitoneal Spread in Colonic Cancer
• IRinotecan and Oxaliplatin for Colon Cancer in Adjuvant Setting
• PK/PD Investigation of Calciumfolinat in Blood, Tumor and Adjacent Mucosa in Patient With Colon Cancer
• Multimodal Narcotic Limited Perioperative Pain Control With Colorectal Surgery
• Study on Aspirin Versus Placebo in Resected Colon Cancer With PI3K Mutation Stage III or II High Risk
• Evaluation of New Histoprognostic Criteria in a Retrospective Study of Colon Cancers Operated at Amiens University Hospital
• Patient Satisfaction With Propofol for Out Patient Colonoscopy
• Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
• Perioperative Chemotherapy VS Postoperative Chemotherapy for the Treatment of Colon Cancer With Resectable Liver Metastasis
• Chemopreventive Effects of Epigallocatechin Gallate (EGCG) in Colorectal Cancer (CRC) Patients
• A Phase II Study of Tegafur-Uracil as Maintenance Chemotherapy in Patients With Stage II of Colon Cancer
• Neoadjuvant Chemotherapy for the Treatment of Resectable Locally Advanced Colon Cancer
• TAS-OX for Refractory Metastatic Colon Cancer
• Maintenance Tegafur-uracil Versus Observation Following Adjuvant Oxaliplatin-based Regimen in Patients With Stage III Colon Cancer After Radical Resection
• Pembrolizumab + Poly-ICLC in MRP Colon Cancer
• Exploratory Study of ART-123 for the Prevention of Cancer Treatment Related Symptoms in Patients With Postoperative Stage II / III Colon Cancer
• Laparoscopic Surgery VS Laparoscopic Surgery + Neoadjuvant Chemotherapy for T4 Tumor of the Colon Cancer
• Predictive Biomarkers of Biological Activity and Efficacy of Nilotinib on ZAK Target in Non-metastatic Colon Cancer
• Curcumin in Combination With 5FU for Colon Cancer
• A Study of Niclosamide in Patients With Resectable Colon Cancer
• Imatinib as Pre-operative Anti-Colon Cancer Targeted Therapy
• A Study Evaluating Regorafenib Following Completion of Standard Chemotherapy for Patients With Colon Cancer
• Aquamin and Prevention of Colon Cancer
• L-Menthol Infusion as a Novel Technique During Colonoscopy
• A Study of Bevacizumab (Avastin) in Combination With Chemotherapy in Participants With Metastatic Cancer of the Colon or Rectum
• Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer
• FOLFOX or CAPOX Perioperative Chemotherapy Versus Postoperative Chemotherapy for Locally Advanced Colon Cancer (OPTICAL)
• Assessment of the Anesthetic Effect on the Activity of Immune Cell in Patient With Colon Cancer
• Assessing How the Viscosity of Submucosal Gel Injections Helps With Endoscopic Mucosal Resections
• Synergistic Anti-tumor Effect of ChangTai Keli for Colon Cancer Patients
• Finding the Best Dose of Aspirin to Prevent Lynch Syndrome Cancers
• Safety of Xeloda in Solid Tumours
• Adjuvant Aspirin Treatment for Colon Cancer Patients
• RhGM-CSF as Adjuvant Immunotherapy in Treating Stage III Colon Cancer
• Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
• A Multi-center Randomized Controlled Trial of Intraportal Chemotherapy Combined With Adjuvant Chemotherapy (mFOLFOX6) for Stage II and III Colon Cancer
• Nintedanib and Capecitabine in Treating Patients With Refractory Metastatic Colorectal Cancer
• A Study of rSIFN-co in Subjects With Advanced Solid Tumors
• Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy
• Different Bowel Preparations in CT Colonography: is Diet Necessary? A Randomized Controlled Trial
• Colectomy in Patients With Asymptomatic and Unresectable Stage IV Colon Cancer
• Influence of Epidural Analgesia on Natural Killer Cell (NK) Activity After Colonic Cancer Surgery
• Effects of Different Types of Perioperative Analgesia on Minimal Residual Disease Development After Colon Cancer Surgery
• A Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients
• A Phase Ⅱ Study of XELOX Chemotherapy With or Without Surgery of Primary Lesion for Colon Cancer Patients
• Cytokine-induced Killer Cell Immunotherapy for Surgical Resected Stage III Colorectal Cancer Patients After Chemotherapy
• Observational Study to Evaluate the Use of Targeted Therapies in Metastatic Colorectal Cancer
• Ziv-Aflibercept Followed by Ziv-Aflibercept, Fluorouracil, and Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer
• CPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery
• Effect of Omega-3 Fatty Acids on the Perioperative Immune Response and Erythrocyte Function
• Adjuvant HIPEC in High Risk Colon Cancer
• Vitamin D in Patients With Stage I-III Colon Cancer or Resectable Colon Cancer Liver Metastases
• Genotype-Directed Study Of Irinotecan Dosing In FOLFIRI + BevacizumabTreated Metastatic Colorectal Cancer
• Glucagon Use in Colonoscopies
• An Investigational Immuno-therapy Study of Nivolumab, and Nivolumab in Combination With Other Anti-cancer Drugs, in Colon Cancer That Has Come Back or Has Spread
• MEK Inhibitor MEK162 in Combination With Leucovorin Calcium, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Metastatic Colorectal Cancer
• A Study Evaluating Veliparib as a Single Agent or in Combination With Chemotherapy in Subjects With Solid Tumors
• Resection vs no Resection of the Primary in Colorectal Cancer With Unresectable Metastases
• A Study to Evaluate the Effects of Veliparib on Heart Rhythms in Patients With Solid Tumors
• Genistein in Treatment of Metastatic Colorectal Cancer
• Cancer and Anesthesia: Survival After Radical Surgery - a Comparison Between Propofol or Sevoflurane Anesthesia
• SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC)
• Short-Infusion Ziv-aflibercept in Treating Patients With Metastatic Colorectal Cancer Receiving Combination Chemotherapy
• Irinotecan and Alisertib in Treating Patients With Advanced Solid Tumors or Colorectal Cancer
• Neoadjuvant Chemotherapy Versus Standard Treatment in Patients With Locally Advanced Colon Cancer
• Lymphoseek® as Lymphoid Tissue Targeting Agents in Colon Cancer(CNC)
• Pre-operative Decitabine in Colon Cancer: a Proof of Principle Study
• Standard and High Dose Irinotecan Based on UGT1A1 Genotype for First-line Treatment of Locally Advanced Colon Cancer
• Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab
• 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy
• Akt Inhibitor MK2206 in Treating Patients With Previously Treated Colon or Rectal Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery
• Trial on Mechanical Bowel Preparation in Laparoscopic Colorectal Surgery
• Physiological Effects of Altering Cancer-related Inflammation
• A Dose Finding Study of Eribulin Mesylate and Cetuximab For Patients With Advanced Head and Neck and Colon Cancer
• A Trial of Maintenance ADAPT Therapy With Capecitabine and Celecoxib in Patients With Metastatic Colorectal Cancer
• Pharmacodynamic and Clinical Evaluation of Dose and Taste-optimised Low Volume PEG-based Bowel Cleansing Solutions Using the Split-dosing Intake Regimen in Healthy Subjects and in Subjects Undergoing Screening Colonoscopy
• PK/PD Investigation of Modufolin (Arfolitixorin) in Plasma, Tumor and Adjacent Mucosa Adjacent Mucosa in Patients With Colon Cancer
• An Observational Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer, Colon Cancer in the Adjuvant Setting, Advanced Gastric Cancer or Breast Cancer
• Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies
• Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer
• Polyphenon E in Treating Patients With High-Risk of Colorectal Cancer
• Dose Finding Study of Once or Twice Weekly IMMU-130 in Metastatic Colorectal Cancer
• Yoga and Bolus Lukewarm Saline as Rapid Colonoscopy Preparation
• Combined Anticancer Treatment of Advanced Colon Cancer
• A Study of Neoadjuvant Photodynamic Immunomodulation for Colon Cancer
• Randomized Phase II Adjuvant Chemotherapy ± FANG™ in Colorectal Carcinoma With Liver Metastases
• Combining Curcumin With FOLFOX Chemotherapy in Patients With Inoperable Colorectal Cancer
• Phase 2 Study of Thermodox as Adjuvant Therapy With Thermal Ablation (RFA) in Treatment of Metastatic Colorectal Cancer(mCRC)
• An Observational Study of Adjuvant Treatment With Capecitabine (Xeloda) in Combination With Oxaliplatin in Participants With Stage III Colon Cancer
• Anti-CD3 x Anti-Erbitux® Armed Activated T Cells (Phase Ib) for Gastrointestinal (GI Cancer)
• CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors
• Sorafenib Tosylate, Bevacizumab, Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer
• Linifanib in Treating Patients With Advanced, Refractory Colorectal Cancer
• Complete Neoadjuvant Treatment for REctal Cancer (CONTRE)
• An Open Dose-finding Study of Oral Applied Hexaminolevulinate (HAL) Imaging in Patients With Suspicion or High Risk of Neoplasia in the Colon
• Improving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had Chemotherapy
• A Pilot Trial of GI-4000 Plus Bevacizumab and Either FOLFOX or FOLFIRI
• Combination Chemotherapy and Bevacizumab Before Surgery and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer
• Adjuvant Therapy(3 vs. 6 Months) With the FOLFOX 4 or XELOX for Stage II or Stage III Colon Cancer
• Study of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer
• Study of Skin Toxicity of Cetuximab: Find a Link Between Skin Inflammation and Tumor Response
• AZD6244 With Cetuximab for Solid Tumors and Colorectal Cancer
• Effect of Celecoxib on Perioperative Inflammatory Response in Colon Cancer
• Combination Chemotherapy and Bevacizumab With or Without RO4929097 in Treating Patients With Metastatic Colorectal Cancer
• Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer
• Study to Assess the Tolerability, Safety and Efficacy of an Adapted Gut Cleansing Solution in Routine Colon Cleansing Prior to Colonoscopies
• Panobinostat and Fluorouracil Followed By Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer Who Did Not Respond to Previous Fluorouracil-Based Chemotherapy
• Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors
• Selumetinib and Cetuximab in Treating Patients With Refractory Solid Tumors
• Ridaforolimus With Cetuximab: Adv Non-Small Cell Lung, Colorectal, Head & Neck Cancer
• Radiolabeled Monoclonal Antibody Therapy, Combination Chemotherapy, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
• Phase I Study of Cetuximab With RO4929097 in Metastatic Colorectal Cancer
• Miralax (PEG 3350) vs. Golytely as Bowel Preparation for Screening Colonoscopy
• A Study of Bevacizumab (Avastin) in Combination With Chemotherapy in Participants With Metastatic Cancer of the Colon or Rectum.
• Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer
• RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors
• Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
• Study of JI-101 in Patients With Advanced Low Grade Endocrine Tumors, Ovarian Cancers or K-RAS Mutant Colon Cancers
• Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors
• Lenalidomide and Cetuximab in Treating Patients With Metastatic Colorectal Cancer
• RO4929097 in Treating Patients With Metastatic Colorectal Cancer
• Clinical and Translational Study of STA-9090
• Neoadjuvant Treatment of Colon Cancer
• Azacitidine and Entinostat in Treating Patients With Metastatic Colorectal Cancer
• Study of Micrometastases in Patients With Stage I or Stage II Localized Colon Cancer That Can Be Removed by Surgery
• Study Investigating the Role of Oxaliplatin Duration in Modified FOLFOX-6 or CAPOX Regimen as Adjuvant Colon Cancer Therapy
• Safety of BKM120 Monotherapy in Advanced Solid Tumor Patients
• Study of Perifosine + Capecitabine for Colon Cancer Patients
• Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer
• Study of Pazopanib and Ixabepilone in Patients With Solid Tumors
• Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
• Preoperative Chemosensitivity Testing to Predict Treatment Benefit in Adjuvant Stage III Colon Cancer
• Dose-Escalation Study in Advanced Colon Cancer Patients
• Thromboprophylaxis for Patients Undergoing Surgical Resection for Colon Cancer
• Combination Chemotherapy for 3 Months or 6 Months in Treating Patients With Stage III Colon Cancer
• Vorinostat, Fluorouracil, and Leucovorin Calcium in Treating Patients With Metastatic Colorectal Cancer That Has Not Responded to Previous Treatment
• Cediranib Maleate and Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer
• Drug-Eluting Bead, Irinotecan (DEBIRI) Therapy of Liver Metastasis From Colon Cancer With Systemic Fluorouracil, Oxaliplatin, Leucovorin and Bevacizumab
• A Phase 1, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Dimethane Sulfonate (DMS612) in Advanced Malignancies
• Dipeptide Alanyl Glutamine and Postoperative Insulin Resistance in Colon Carcinoma Patients
• Identifying Prognostic Factors in Patients Receiving Tegafur-Uracil for Stage II Colon Cancer That Was Completely Removed By Surgery
• Outpatient Health Care Program for Older Patients Receiving Chemotherapy for Newly Diagnosed Breast Cancer or Colon Cancer
• Exploratory Study Of The ERCC-1 Gene
• A Study of Irinotecan and Cetuximab With or Without IMC-A12 for Treatment of Participants With Colon or Rectum Cancer Who Got Worse After Their First Treatment With Oxaliplatin and Bevacizumab
• Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surgery
• Eniluracil Hand Foot Syndrome
• Neoadjuvant FOLFOX Plus Bevacizumab Chemotherapy in Patients With Locally Advanced Colon Cancer
• Sorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
• PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) Tumors
• Safe, Effective, and More Tolerable 16 Tablets Colon Prep
• A Safety Study of Pentamidine in Patients With Metastatic Colon Cancer Undergoing Standard Chemotherapy as Second-line and/or Third-line Treatment
• Panitumumab Combination Study With Rilotumumab or Ganitumab in Wild-type Kirsten Rat Sarcoma Virus Oncogene Homolog (KRAS) Metastatic Colorectal Cancer (mCRC)
• Yttrium Microspheres With Cetuximab Plus Irinotecan for Patients With Advanced Colorectal Cancer Mets to Liver
• BLI850 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy
• BLI850-302: BLI850 vs an Approved Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy
• Erlotinib Hydrochloride in Treating Patients With Stage I-III Colorectal Cancer or Adenoma
• A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjects With Previously Treated Metastatic Colorectal Carcinoma
• Efficacy of Morning-only Bowel Preparation for Afternoon Colonoscopy.
• Regional Anesthesia in Colon Rectal Surgery
• NGR-hTNF Administered in Combination With a Standard Oxaliplatin Based Regimen in Patients With Metastatic Colorectal Cancer
• Mangafodipir as an Adjunct to FOLFOX6 Chemotherapy in Colon Cancer Stage Dukes' C
• Tegafur-Uracil and Leucovorin or S-1 in Treating Patients With Stage III Colon Cancer That Has Been Completely Removed by Surgery
• Fluorouracil and Oxaliplatin With or Without Panitumumab In Treating Patients With High-Risk Colon Cancer That Can Be Removed by Surgery
• FOLFOX-4 3months Versus 6 Months and Bevacizumab as Adjuvant Therapy for Patients With Stage II/III Colon Cancer
• Hepatic Arterial Infusion of Floxuridine, Gemcitabine Hydrochloride, and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer Previously Treated With Surgery
• Phase 1b/2 Study of AMG 655 With mFOLFOX6 and Bevacizumab for First-Line Metastatic Colorectal Cancer
• Phase II Trial of Abraxane and Capecitabine in Metastatic Colon Cancer (COL 01)
• A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)
• OBELIX Study: A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Cancer of the Colon or Rectum.
• Veliparib and Irinotecan Hydrochloride in Treating Patients With Cancer That Is Metastatic or Cannot Be Removed by Surgery
• Pertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer
• First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study
• Concentration of Ertapenem in Colorectal Tissue
• Dasatinib in Treating Patients With Previously Treated Metastatic Colorectal Cancer
• A Study of Xeloda (Capecitabine) as Adjuvant Monotherapy in Patients With Colon Cancer.
• Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
• A Study of the Perioperative Use of Cetuximab in Colon Cancer Patients
• Safety Study of Recombinant NAPc2 to Prevent Tumor Progression and Metastases in Metastatic Colon Cancer
• Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By Surgery
• Fluorouracil, Semustine, and Vincristine Compared With BCG in Treating Patients With Dukes' B or Dukes' C Colon Cancer That Has Been Removed By Surgery
• Effect of Postoperative Laxative on Bowel Function After Colonic Surgery
• Liver Infusions of Fluorouracil in Treating Patients With Dukes' A, Dukes' B, or Dukes' C Colon Cancer Undergoing Surgery
• Comparison of 2L NRL994 With NaP Preparation in Colon Cleansing Prior to Colonoscopies for Colon Tumor Screening
• Fluorouracil and Leucovorin and/or Levamisole After Surgery In Treating Patients With Dukes' B Or Dukes' C Colon Cancer
• VEGF Trap in Treating Patients With Previously Treated Metastatic Colorectal Cancer
• AZD0530 (NSC 735464) in Treating Patients With Previously Treated Metastatic Colon Cancer or Rectal Cancer
• Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer
• A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Stage 2B or 3 Locally Advanced, Colon Cancer
• A Study of ZYC300 Administered With Cyclophosphamide Pre-Dosing
• Combination Chemotherapy in Treating Patients With Resected Colon Cancer
• Irinotecan and Cetuximab for Colorectal Cancer as Second Line Therapy
• Skin Toxicity Treatment in Metastatic Colorectal Cancer (mCRC) Patients Receiving Panitumumab + Irinotecan-based Therapy
• Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colon Cancer That Cannot Be Removed By Surgery
• Randomized Trial on Adjuvant Chemotherapy in Colon Carcinoma Dukes B
• Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Colon Carcinoma Dukes C
• Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Metastatic Colon Cancer
• IVIG in the Treatment of Metastatic Cancers of the Prostate, Colon and Melanoma
• Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Metastatic Colon Cancer
• MOSAIC - Multicenter International Study of Oxaliplatin/ 5FU-LV in the Adjuvant Treatment of Colon Cancer
• Combination Chemotherapy With or Without Cetuximab in Treating Patients With Stage III Colon Cancer That Was Completely Removed By Surgery
• MASCOT : Multicenter Asia Study in Adjuvant Treatment of Colon Cancer With OxaliplaTin/5FU-LV
• GM-CSF and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Colon Cancer
• Cellular Immune Augmentation in Colon and Rectal Cancer
• Resveratrol for Patients With Colon Cancer
• A Study of MLN8054 in Patients With Advanced Solid Tumors
• Clinical Trial in Patients With Metastatic Colorectal Cancer
• Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
• Prospective Phase II Randomized Trial of Postoperative Adjuvant Chemotherapy in Patients With High Risk Colon Cancer
• Study Evaluating Isovorin in Colon Cancer
• Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal Cancer
• Enzastaurin for Patients With Metastatic Colorectal Cancer
• Imaging Colo-rectal Cancer Using a Two Step Antibody Technique in Nuclear Imaging
• Study of Xeloda and Gleevec in Patients With Advanced Solid Tumors
• MEK Inhibitor PD-325901 To Treat Advanced Breast Cancer, Colon Cancer, And Melanoma.
• Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors
• Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal Cancer
• Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to 5-Fluorouracil Based Chemotherapy in Stage III Colon Cancer
• Trial for Microarray Analysis of Colon Cancer Outcome-A (MACCO-A)
• Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for High Risk Stage II or Stage III Colon Cancer
• SB-715992 in Treating Patients With Advanced or Metastatic Colorectal Cancer
• Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer
• Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal Cancer
• Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer
• Chemotherapy Administered Every 2 Weeks With or Without Pegfilgrastim in Subjects With Advanced or Metastatic Colon Cancer
• Fluorouracil and Irinotecan With or Without Leucovorin Compared With Observation in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
• Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors
• Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal Cancer
• Celecoxib in Preventing Polyps in Patients Who Have Undergone Surgery for Stage I Colon Cancer
• EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer
• GTI-2040, Oxaliplatin, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer or Other Solid Tumors
• Clinical Trial in Patients With Metastatic Colorectal Cancer
• Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
• Bevacizumab and Cetuximab With or Without Irinotecan in Treating Patients With Irinotecan-Refractory Metastatic Colorectal Cancer
• Study Evaluating EKB-569 in Advanced Colorectal Cancer
• Neoadjuvant and Adjuvant Capecitabine and Oxaliplatin in Treating Patients With Resectable Liver Metastases Secondary to Colorectal Cancer
• Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal Cancer
• A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
• Study Evaluating MAC-321 in Colorectal Cancer
• A Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, and Oxaliplatin) and Bevacizumab (Avastin) in Patients With Advanced Colorectal Cancer
• Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.
• Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer
• Gefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal Cancer
• Combination Chemotherapy in Treating Patients With Colon Cancer
• Safety Study of hMN14 to Treat Either Colorectal or Breast Cancer
• Imatinib Mesylate in Treating Patients With Stage IV Colorectal Cancer
• Safety Study of 90Y-hMN14 to Treat Colorectal Cancer
• EPO906 Therapy in Patients With Advanced Colorectal Cancer
• Erlotinib in Treating Patients With Recurrent or Metastatic Colorectal Cancer
• 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)
• Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction
• Hepatic Arterial Infusion Plus Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver
• Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated
• Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Recurrent or Persistent Metastatic Colorectal Cancer
• Vaccine Therapy in Treating Patients With Metastatic Cancer
• Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the Liver
• Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer
• Vaccine Therapy in Treating Patients With Stage II or Stage III Colon Cancer That Has Been Removed During Surgery
• A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer
• Combination Chemotherapy With or Without Irinotecan in Treating Patients With Stage III Colon Cancer
• SU5416 and Irinotecan in Treating Patients With Advanced Colorectal Cancer
• Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove Polyps
• Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
• Fluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients With Stage II or Stage III Colon Cancer
• Treatment of Peritoneal Cancer With Surgery, Perfused Heated Cisplatin and Chemotherapy
• High-Dose Fluorouracil With or Without Leucovorin Compared With Standard Fluorouracil Plus Leucovorin Following Surgery in Treating Patients With Stage III Colon Cancer
• Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal Cancer
• Combination Chemotherapy in Treating Patients With Stage III Colon Cancer
• Antineoplaston Therapy in Treating Patients With Colon Cancer
• Antineoplaston Therapy in Treating Patients With Metastatic or Unresectable Colon Cancer
• Radiation Therapy Plus Irinotecan in Treating Patients With Colon Cancer
• Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal Cancer
• S9415 Chemotherapy in Patients With Stage II or III Colon Cancer That Has Been Surgically Removed
• Perioperative Chemotherapy in Treating Patients With Colon Cancer That Can Be Surgically Removed
• A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by Rituximab
• Women's Health Initiative (WHI)